Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats

Stroke

Volumn 33, Issue 9, 2002, Pages 2156-2163

  Takeda, Hidetaka ^a,d   Spatz, Maria ^a   Ruetzler, Christl ^a   McCarron, Richard ^b   Becker, Kyra ^c   Hallenbeck, John ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d KEIO UNIVERSITY   (Japan)

Author keywords

E selectin; Endothelium; Immune tolerance; Rats; Risk factors

Indexed keywords

ANTIBODY; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LYMPHOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL CORTEX; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DRUG EVALUATION, PRECLINICAL; E-SELECTIN; GENETIC PREDISPOSITION TO DISEASE; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; INSTILLATION, DRUG; LIPOPOLYSACCHARIDES; LYMPHOCYTES; NASAL MUCOSA; OVALBUMIN; RATS; RATS, INBRED SHR; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036712364     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000029821.82531.8B     Document Type: Article

References (39)

1. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque
2. Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction
3. Inflammatory pathways in atherosclerosis and acute coronary syndromes
4. Vascular-bed-specific hemostasis and hypercoagulable states
5. Brain vessels normally undergo cyclic activation and inactivation: Evidence from tumor necrosis factor-alpha, heme oxygenase-1, and manganese superoxide dismutase immunostaining of vessels and perivascular brain cells
6. Proinflammatory cytokine expression contributes to brain injury provoked by chronic monocyte activation
7. Class II MHC antigen expression by cultured human cerebral vascular endothelial cells
8. Endothelial function and hemostasis
9. Cytokines and endothelial cell biology
10. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia
11. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
12. Peripheral deletion of antigen-reactive T cells in oral tolerance
13. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
14. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
15. Oral tolerance: Mechanisms and therapeutic applications
16. Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis
17. Selectins
18. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins
19. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription
20. Endothelial-leukocyte adhesion molecules
21. Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue
22. P-selectin, and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion
23. Symptomatological classification in the development of stroke in stroke-prone spontaneously hypertensive rats
24. Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia
25. T-cell function and migration: Two sides of the same coin
26. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering
27. Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues
28. Perturbation of the T-cell repertoire in patients with unstable angina
29. The endothelial cell as a regulator of T-cell function
30. Evidence for endocytosis of E-selectin in human endothelial cells
31. Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes
32. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases
33. Mechanisms of interleukin-10-mediated immune suppression
34. Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor
35. Characterization of E-selectin-deficient mice: Demonstration of overlapping function of the endothelial selectins
36. Anti-endothelial cell antibodies in patients with coronary atherosclerosis
37. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis
38. Functional heterogeneity of anti-endothelial cell antibodies
39. T-cell immunity in acute coronary syndromes